Clinical Trial Update: Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating smoking abstinence and lapse effects in smokers with schizophrenia and in control participants; the study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Tobacco Use Disorder

Snippet

Sponsor: Brown University | Conditions: Tobacco Use Disorder, Schizophrenia | Phase 2 | Status: COMPLETED